Clinical application of endothelial injury marker in hypertensive patients

Xiao Qian Guo1, Wei Ren1, Rui Peng1

  • 1Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Insights

Thrombomodulin levels increase with higher blood pressure and hypertension complications, indicating greater endothelial injury. This suggests thrombomodulin is a valuable marker for tracking hypertension progression.

Area of Science:

  • Cardiovascular Research
  • Hypertension Studies
  • Endothelial Function

Background:

  • Endothelial damage is a primary driver of persistent hypertensive complications.
  • Identifying reliable markers for endothelial damage is crucial for managing hypertension.

Purpose of the Study:

  • To investigate the relationship between thrombomodulin, a marker of endothelial damage, and hypertensive complications.
  • To assess thrombomodulin as a potential indicator of hypertension progression.

Main Methods:

  • 132 hypertensive patients were studied, categorized by blood pressure levels.
  • Plasma thrombomodulin levels were measured and correlated with blood pressure and organ damage.
  • Patient medical histories, including lifestyle factors, were analyzed.

Main Results:

  • Subjects with hypertensive complications exhibited significantly higher plasma thrombomodulin concentrations (24.5 TU/mL) compared to those without (12.1 TU/mL).
  • A thrombomodulin cutoff value of 15.5 TU/mL demonstrated 92.3% sensitivity and 63% specificity for identifying complications.
  • Thrombomodulin levels showed a statistically significant increasing trend with escalating blood pressure categories (P = .007).

Conclusions:

  • Elevated thrombomodulin levels correlate with increased blood pressure and the presence of hypertensive complications.
  • The observed trend suggests thrombomodulin reflects the degree of endothelial injury in hypertension.
  • Thrombomodulin emerges as a clinically significant biomarker for monitoring hypertension progression.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
610
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
984
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.5K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
777
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
1.4K